Germany – Miscellaneous health services – Zulassungsverfahren zum Vertrag zur Besonderen Versorgung nach § 140a SGB V zur Verbesserung der poststationären Weiterbehandlung am Beispiel kardiologischer Erkrankungen "Cardiolotse"

Health · Germany government procurement

Closed September 01, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Germany – Miscellaneous health services – Approval procedure for the contract for special care pursuant to Section 140a of the German Social Code, Book V (SGB V) for the improvement of post-hospital follow-up treatment using the example of cardiological diseases "Cardiolotse"

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryHealth Services
PublishedFebruary 12, 2024
Procurement stageActive solicitation
ClosedSeptember 01, 2026
StatusClosed — no longer accepting responses
TranslationTranslated from German by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Compulsory social security services – Abschluss von Kooperationsvereinbarungen zur Vermittlung von Mitgliedschaften
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Tetrabenazin (ATC: N07XX06)
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-19 - Tafamidis
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Liraglutid, ATC A10BJ02
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Sultamicillin (ATC J01CR04).
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sunitinib, ATC L01EX01
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Peginterferon alfa-2a, ATC L03AB11
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Bevacizumab, ATC L01FG01

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.